B. Thürlimann
Impact in
-
- Bone health and treatments
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 8
- Bone health and treatments 4
- Cancer Treatment and Pharmacology 2
-
- Breast Cancer Treatment Studies 5
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Hervé Bonnefoi (1 shared paper)M. Castiglione (1 shared paper)Martin F. Fey (1 shared paper)R. Morant (1 shared paper)F. Cavalli (1 shared paper)JF Forbes (2 shared papers)AS Coates (3 shared papers)A. Goldhirsch (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)British Journal of Cancer (1 paper)European Journal of Cancer (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
B. Thürlimann
13 papers receiving 136 citations
Peers
Comparison fields: 5 of 40
- Oncology 113
- Cancer Research 43
- Orthopedics and Sports Medicine 19
- Genetics 56
- Pulmonary and Respiratory Medicine 32
Countries citing papers authored by B. Thürlimann
This map shows the geographic impact of B. Thürlimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Thürlimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Thürlimann more than expected).
Fields of papers citing papers by B. Thürlimann
This network shows the impact of papers produced by B. Thürlimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Thürlimann. The network helps show where B. Thürlimann may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Thürlimann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 51 | |
| 2 | 1998 | 33 | |
| 3 | 1999 | 32 | |
| 4 | 2014 | 9 | |
| 5 | 1993 | 7 | |
| 6 | 2011 | 6 | |
| 7 | Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from trial BIG 1-98 comparing adjuvant endocrine therapy with tamoxifen versus letrozole | 2008 | 3 |
| 8 | 1991 | 2 | |
| 9 | 2016 | 2 | |
| 10 | 1995 | 2 | |
| 11 | 2018 | 1 | |
| 12 | 2011 | 1 | |
| 13 | 1999 | 1 | |
| 14 | [Hormone therapy of metastasizing breast carcinoma]. | 1996 | 0 |
| 15 | 2011 | 0 |
About B. Thürlimann
B. Thürlimann is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 15 papers that have together received 150 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (5 papers), Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (2 papers), Cancer, Lipids, and Metabolism (2 papers), Advanced Breast Cancer Therapies (2 papers), Bone health and osteoporosis research (1 paper) and Medical Imaging and Pathology Studies (1 paper). The work is most often cited by research in Oncology (113 citations), Cancer Research (43 citations), Orthopedics and Sports Medicine (19 citations), Genetics (56 citations) and Pulmonary and Respiratory Medicine (32 citations). B. Thürlimann has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Hervé Bonnefoi, M. Castiglione, Martin F. Fey, R. Morant, F. Cavalli, JF Forbes, AS Coates, A. Goldhirsch, Monica Castiglione‐Gertsch and Z. Herrmann. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, British Journal of Cancer, European Journal of Cancer and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.